According to Xu Feng, the director of Shanghai Jiucheng Law Firm, based on the above information, investors who bought Ningxia Zhongke Biotechnology stocks between November 22, 2022, and April 6, 2023, and sold or continue to hold stocks after April 6, 2023, can currently initiate a claim.
宁科生物（600165）投资者索赔已有胜诉，后续投资者还可起诉
Investors have already won the lawsuit for Ningxia Zhongke Biotechnology (600165), and subsequent investors can still file claims.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.